cas 15813-08-8|| where to buy 4-bromo-5-methyl-1H-imidazole

Produktname:4-bromo-5-methyl-1H-imidazole

IUPAC Name:4-bromo-5-methyl-1H-imidazole

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM101992-5g	in stock	ŪȖ
CM101992-10g	in stock	ȤŪœ
CM101992-25g	in stock	ŸŪȖ
CM101992-100g	in stock	ȤŸȤƐ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 15813-08-8 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:15813-08-8; Molekulare Formel:C4H5BrN2; Schmelzpunkt:-; SMILES-Code:CC1=C(Br)N=CN1; Dichte:1.723 g/cm3

: Katalognummer:CM101992; Molekulargewicht:161; Siedepunkt:328.5°C at 760 mmHg; Mdl-Nr.:MFCD06659898; Lagerung:Store at room temperature.

: Imidazoles; Imidazole is an important five-membered nitrogen-containing heterocyclic compound. Among the numerous heterocyclic compounds, imidazole and its derivatives are regarded as a unique and multifaceted scaffold material due to their diverse applications in industrial, organic and pharmaceutical chemistry. Imidazoles interact in different ways with many therapeutic targets, enzymes and receptors in biological systems and thus exhibit a wide range of biological activities. In particular, several imidazoles can be used as clinical drugs to treat various types of cancer with high therapeutic efficacy. Furthermore, imidazoles are one of the most critical segments in the field of anti-covid-19 virus drug discovery due to their ability to interact with active targets in living systems.; Imidazole Manufacturer; As a professional imidazole manufacturer, we can guarantee product quality and delivery time.our company has been committed to supply personalized product solutions to customers,pls consult us.